Page 130 - SUBSEC October 2017_Neat
P. 130
- 12 -
(b) Recombinant DNA (R-DNA ) technology produces Humulin (human insulin) which is
used to treat diabetes. Describe the steps in the R-DNA process, and suggest THREE
advantages of obtaining insulin by this method over other methods.
Steps ...................................................................................................................................
.............................................................................................................................................. DO NOT WRITE IN THIS AREA
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
.............................................................................................................................................. DO NOT WRITE IN THIS AREA
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
.............................................................................................................................................. DO NOT WRITE IN THIS AREA
..............................................................................................................................................
..............................................................................................................................................
..............................................................................................................................................
GO ON TO THE NEXT PAGE
02107020/CAPE/SPEC 2017
‘‘*’’Barcode Area”*”
Sequential Bar Code
